STS-135 (drug)

From Wikipedia, the free encyclopedia
Jump to: navigation, search
STS-135 (drug)
STS-135 structure.png
Systematic (IUPAC) name
N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide
Clinical data
Legal status Temporary class drug (NZ)
Identifiers
CAS number 1354631-26-7
ATC code ?
Chemical data
Formula C24H31FN2O 
Mol. mass 382.51 g/mol

STS-135 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide) is a designer drug offered by online vendors as a cannabimimetic agent. The structure of STS-135 appears to utilise an understanding of structure-activity relationships within the indole class of cannabimimetics, although its design origins are unclear. STS-135 is the terminally-fluorinated analogue of SDB-001, just as AM-2201 is the terminally-fluorinated analogue of JWH-018, and XLR-11 is the terminally-fluorinated analogue of UR-144. No information regarding the in vitro or in vivo activity of STS-135 has been published, and only anecdotal reports are known of its pharmacology in humans or other animals.

Detection[edit]

A forensic standard of STS-135 is available, and the compound has been posted on the Forendex website of potential drugs of abuse.[1]

See also[edit]

References[edit]